Watch Laser Acupuncture With Nasal Radiation for Prevention of Coronary Artery Disease
Laser Hemotherapy Trial for Coronary Artery Disease Prevention in High Risk Patients
1 other identifier
interventional
50
1 country
1
Brief Summary
This study will evaluate the effect of low level laser blood radiation applied to all participants for prevention of coronary artery disease in patients with high risk (hypertension,high blood viscosity, hypercholesterolemia as well as related immune issues)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 25, 2018
CompletedFirst Posted
Study publicly available on registry
March 6, 2018
CompletedStudy Start
First participant enrolled
May 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 5, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2018
CompletedFebruary 7, 2019
February 1, 2019
3 months
February 25, 2018
February 5, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
changes of blood pressure
measuring blood pressure before and after each low level laser radiation
8 weeks
Secondary Outcomes (8)
changes in blood viscosity
8 weeks
change in IL-17 level
45 days
change in functional capacity
70 days
change in CD 8 (cluster of differentiation 8) level
45 days
change in TC (total cholesterol) level
60 days
- +3 more secondary outcomes
Study Arms (2)
low level laser hemotherapy
EXPERIMENTALWatch laser acupuncture and nasal irradiation
control
NO INTERVENTIONall the participants in this group did not receive low level laser irradiation during the study period
Interventions
semiconductor laser therapeutic instrument irradiate the circulating blood in the vessels of left hand acupoint and the mucosal tissue in the nasal cavity
Eligibility Criteria
You may qualify if:
- stage I hypertensive patients
- patients from 30 to 34.9 kg/m2 body mass index
- medically stable patients
- all participants have sufficient cognition enough to understand the requirements of the study
You may not qualify if:
- history of malignant disease
- smoking
- history of progressive fatal disease
- history of drug or alcohol abuse
- blood donation within at least 30 days
- pregnant, trying to be pregnant or breast feeding
- cognitive impairment that will make it difficult to partake in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo
Giza, Dokki, 11432, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cairo Giza, MD
Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer assistance at Cairo University
Study Record Dates
First Submitted
February 25, 2018
First Posted
March 6, 2018
Study Start
May 1, 2018
Primary Completion
August 5, 2018
Study Completion
December 30, 2018
Last Updated
February 7, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- data will be available after 6 months of study completion and ending 36 months
- Access Criteria
- proposals should directed to Dr.EbtesamNagy@cu.edu.eg. To gain access, data requestors will need to sign a data access agreement
De-identified participated data for underlie results reported in this trial